Chongqing Zhifei Stock Hits Day Low of CNY 11.80 Amid Price Pressure

Chongqing Zhifei Biological Products Co., Ltd. experienced a significant decline today, with the stock dropping by 4.1% and reaching an intraday low of CNY 11.80. This performance marks a stark contrast to the China Shanghai Composite, which fell by only 1.7% on the same day. Over the past week, Chongqing Zhifei has seen a notable decrease of 12.92%, and its one-month performance reflects a decline of 22.88%. The company's year-to-date performance stands at a loss of 36.78%, while its one-year performance shows a substantial drop of 38.82%. The long-term outlook is equally concerning, with a staggering 82.1% decline over the past three years and a 93.62% drop over the last five years. Financial metrics reveal a challenging situation for the company, with net sales declining by 4.06% and a net profit of CNY -13,898.61 million, reflecting a significant downturn. The company has reported negative results for ten consecutive quarters, indicating ongoing difficulties in achieving profitability. With a market capitalization of CNY 16,947 million, Chongqing Zhifei continues to face challenges in the competitive pharmaceuticals and biotechnology sector.